The Clinical Trials: World Market 2010-2025 report is released,
especially for your company this report provides valuable
information.
The market for clinical trial services has been expanding rapidly,
with impressive revenue growth and expansion of the sector in recent
years. Our new study shows how that sector will develop from 2010
onwards, with benefits to the pharma industry and clinical service
providers. Clinical research organisations (CROs) are playing
increasingly important roles in drug development worldwide, from
conducting phase I trials to post-marketing studies.
Ageing populations, increasing prevalence of chronic diseases,
growing demand for improved therapies and high growth of the
pharmaceutical and biotechnology markets worldwide are driving the
clinical trials sector and market. The globalisation of development
programmes and the increasing complexity of trials - with regulatory
developments - are heightening the need for larger trials and
greater numbers of trials. Many pharma companies are outsourcing
clinical trials to gain cost savings/efficiencies, greater
flexibility and specialist expertise. That trend will continue from
2010 onwards, our new study - Clinical Trials: World Market
2010-2025 - reveals. The emerging clinical trial destinations,
including CEE countries, India and China, are achieving double-digit
growth, our analyses show.
Our new report considers perspectives of sponsors and CROs for
clinical trial outsourcing/off-shoring. We analyse the sectors
strengths, weaknesses and financial prospects from 2010 to 2025
through quantitative and qualitative analyses. This report provides
hard-to-find data on the current and future values of clinical trial
spending and the CRO market, worldwide and regionally. We address
global questions, such as: what proportion of the sector will be
held by contract research organisations in future years? Our report
also addresses regional questions. For example, how will Indias share
of global spending change between 2010 and 2025? Will the Central
and Eastern European sector expand more rapidly than that of China?
Our new report answers questions such as those, providing the
information that you need.
>> -
http://cts.vresp.com/c/?ASDMediaBV/3dfdb6670e/ee839ee72a/de80a5e913/id=4987&utm_source=LifeScience_Reports&utm_medium=email&utm_campaign=RP_4987_Pharma Click here to find the details of this new market research
(If you cannot open the link: the report is available on
ASDReports.com, just search 'Clinical Trials'.)
If you have any questions on this study or other publications please
contact me directly.
Kind Regards,
Stefan Koopman - ASDMedia BV - Amsterdam - Netherlands
T +31.20.486.9620 - M +31.646.260.577 - F +31.20.486.0216
- ste...@as... ste...@as...
______________________________________________________________________
Click to view this email in a browser
http://hosted.verticalresponse.com/766559/3dfdb6670e/1460514159/ee839ee72a/
If you no longer wish to receive these emails, please reply to this
message with "Unsubscribe" in the subject line or simply click on the
following link:
http://cts.vresp.com/u?3dfdb6670e/ee839ee72a/mlpftw
______________________________________________________________________
This message was sent by ASDReports-LifeScience using
VerticalResponse
ASD Media BV
Veemkade 326
Amsterdam, Noord-Holland 1019HD
Read the VerticalResponse marketing policy:
http://www.verticalresponse.com/content/pm_policy.html
|
